1. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
- Author
-
Reich, Daniel S, primary, Arnold, Douglas L, additional, Vermersch, Patrick, additional, Bar-Or, Amit, additional, Fox, Robert J, additional, Matta, Andre, additional, Turner, Timothy, additional, Wallström, Erik, additional, Zhang, Xinyan, additional, Mareš, Miroslav, additional, Khabirov, Farit A, additional, Traboulsee, Anthony, additional, Grand'Maison, Francois, additional, Jacques, Francois, additional, Tyblova, Michaela, additional, Meluzinova, Eva, additional, Ampapa, Radek, additional, Valis, Martin, additional, Hradilke, Pavel, additional, Stourac, Pavel, additional, Gross-Paju, Katrin, additional, Laplaud, David, additional, Mathey, Guillaume, additional, Uitdehaag, Bernard, additional, Evdoshenkoo, Evgeny, additional, Popova, Ekaterina, additional, Zakharova, Maria, additional, Totolyan, Natalia, additional, Litvinenko, Igor, additional, Khabirov, Farit, additional, Sivertseva, Stella, additional, Hancinova, Viera, additional, Kantorova, Ema, additional, Gines, Maria Luisa Martinez, additional, Montalban, Xavier, additional, Maduano, Sara Eichau, additional, Meca-Lallana, Jose, additional, Ramió-Torrentà, Lluís, additional, Nehrych, Tetyanna, additional, Pashkovskyy, Valeriy, additional, Moskovko, Sergii, additional, Kalbus, Oleksandr, additional, Khavunka, Marta, additional, Pryshchepa, Volodymyr, additional, Goloborodko, Alla, additional, Wynn, Daniel, additional, Honeycutt, William, additional, Wray, Sibyl, additional, Steingo, Brian, additional, LaGanke, Christopher, additional, Huang, Deren, additional, Hemphill, John Michael, additional, Goldstick, Lawrence, additional, and Robertson, Derrick, additional
- Published
- 2021
- Full Text
- View/download PDF